211 related articles for article (PubMed ID: 22789727)
1. A novel resistance mechanism to triclosan that suggests horizontal gene transfer and demonstrates a potential selective pressure for reduced biocide susceptibility in clinical strains of Staphylococcus aureus.
Ciusa ML; Furi L; Knight D; Decorosi F; Fondi M; Raggi C; Coelho JR; Aragones L; Moce L; Visa P; Freitas AT; Baldassarri L; Fani R; Viti C; Orefici G; Martinez JL; Morrissey I; Oggioni MR;
Int J Antimicrob Agents; 2012 Sep; 40(3):210-20. PubMed ID: 22789727
[TBL] [Abstract][Full Text] [Related]
2. Mutations upstream of fabI in triclosan resistant Staphylococcus aureus strains are associated with elevated fabI gene expression.
Grandgirard D; Furi L; Ciusa ML; Baldassarri L; Knight DR; Morrissey I; Largiadèr CR; Leib SL; Oggioni MR
BMC Genomics; 2015 Apr; 16(1):345. PubMed ID: 25924916
[TBL] [Abstract][Full Text] [Related]
3. Small-colony variants: a novel mechanism for triclosan resistance in methicillin-resistant Staphylococcus aureus.
Seaman PF; Ochs D; Day MJ
J Antimicrob Chemother; 2007 Jan; 59(1):43-50. PubMed ID: 17079243
[TBL] [Abstract][Full Text] [Related]
4. Discovery of 4-Pyridone derivatives as specific inhibitors of enoyl-acyl carrier protein reductase (FabI) with antibacterial activity against Staphylococcus aureus.
Takahata S; Iida M; Yoshida T; Kumura K; Kitagawa H; Hoshiko S
J Antibiot (Tokyo); 2007 Feb; 60(2):123-8. PubMed ID: 17420562
[TBL] [Abstract][Full Text] [Related]
5. Defining and combating the mechanisms of triclosan resistance in clinical isolates of Staphylococcus aureus.
Fan F; Yan K; Wallis NG; Reed S; Moore TD; Rittenhouse SF; DeWolf WE; Huang J; McDevitt D; Miller WH; Seefeld MA; Newlander KA; Jakas DR; Head MS; Payne DJ
Antimicrob Agents Chemother; 2002 Nov; 46(11):3343-7. PubMed ID: 12384334
[TBL] [Abstract][Full Text] [Related]
6. [Reduced susceptibility to triclosan in methicillin-resistant Staphylococcus aureus].
Wiśniewska K; Piechowicz L; Galiński J
Med Dosw Mikrobiol; 2006; 58(1):11-7. PubMed ID: 16871968
[TBL] [Abstract][Full Text] [Related]
7. Triclosan resistance in methicillin-resistant Staphylococcus aureus (MRSA).
Brenwald NP; Fraise AP
J Hosp Infect; 2003 Oct; 55(2):141-4. PubMed ID: 14529640
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of antibiotic-resistant cocci to biocides.
Fraise AP
J Appl Microbiol; 2002; 92 Suppl():158S-62S. PubMed ID: 12000624
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal analysis of chlorhexidine susceptibilities of nosocomial methicillin-resistant Staphylococcus aureus isolates at a teaching hospital in Taiwan.
Wang JT; Sheng WH; Wang JL; Chen D; Chen ML; Chen YC; Chang SC
J Antimicrob Chemother; 2008 Sep; 62(3):514-7. PubMed ID: 18477706
[TBL] [Abstract][Full Text] [Related]
10. The association between biocide tolerance and the presence or absence of qac genes among hospital-acquired and community-acquired MRSA isolates.
Smith K; Gemmell CG; Hunter IS
J Antimicrob Chemother; 2008 Jan; 61(1):78-84. PubMed ID: 17981834
[TBL] [Abstract][Full Text] [Related]
11. A triclosan-ciprofloxacin cross-resistant mutant strain of Staphylococcus aureus displays an alteration in the expression of several cell membrane structural and functional genes.
Tkachenko O; Shepard J; Aris VM; Joy A; Bello A; Londono I; Marku J; Soteropoulos P; Peteroy-Kelly MA
Res Microbiol; 2007; 158(8-9):651-8. PubMed ID: 17997080
[TBL] [Abstract][Full Text] [Related]
12. Importance of sigma factor mutations in increased triclosan resistance in Salmonella Typhimurium.
Gantzhorn MR; Olsen JE; Thomsen LE
BMC Microbiol; 2015 May; 15():105. PubMed ID: 25986727
[TBL] [Abstract][Full Text] [Related]
13. Triclosan-tolerant bacteria: changes in susceptibility to antibiotics.
Cottell A; Denyer SP; Hanlon GW; Ochs D; Maillard JY
J Hosp Infect; 2009 May; 72(1):71-6. PubMed ID: 19246121
[TBL] [Abstract][Full Text] [Related]
14. Signature gene expression profile of triclosan-resistant Escherichia coli.
Yu BJ; Kim JA; Pan JG
J Antimicrob Chemother; 2010 Jun; 65(6):1171-7. PubMed ID: 20410062
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of antibiotic-resistant cocci to biocides.
Fraise AP
Symp Ser Soc Appl Microbiol; 2002; (31):158S-162S. PubMed ID: 12481840
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic chlorhexidine and triclosan susceptibility in clinical Staphylococcus aureus isolates in Australia.
Hughes C; Ferguson J
Pathology; 2017 Oct; 49(6):633-637. PubMed ID: 28811083
[TBL] [Abstract][Full Text] [Related]
17. Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008).
Castanheira M; Watters AA; Mendes RE; Farrell DJ; Jones RN
J Antimicrob Chemother; 2010 Jul; 65(7):1353-8. PubMed ID: 20430787
[TBL] [Abstract][Full Text] [Related]
18. Triclosan resistance in methicillin-resistant Staphylococcus aureus expressed as small colony variants: a novel mode of evasion of susceptibility to antiseptics.
Bayston R; Ashraf W; Smith T
J Antimicrob Chemother; 2007 May; 59(5):848-53. PubMed ID: 17337510
[TBL] [Abstract][Full Text] [Related]
19. Indole naphthyridinones as inhibitors of bacterial enoyl-ACP reductases FabI and FabK.
Seefeld MA; Miller WH; Newlander KA; Burgess WJ; DeWolf WE; Elkins PA; Head MS; Jakas DR; Janson CA; Keller PM; Manley PJ; Moore TD; Payne DJ; Pearson S; Polizzi BJ; Qiu X; Rittenhouse SF; Uzinskas IN; Wallis NG; Huffman WF
J Med Chem; 2003 Apr; 46(9):1627-35. PubMed ID: 12699381
[TBL] [Abstract][Full Text] [Related]
20. Triclosan and antibiotic resistance in Staphylococcus aureus.
Suller MT; Russell AD
J Antimicrob Chemother; 2000 Jul; 46(1):11-8. PubMed ID: 10882683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
